Recent Updates
Recently added Catalysts
LNAI Positive Sentiment Score: 70/100

Renovaro Biosciences Announces Results of Special Meeting of Shareholders Los Angeles

Thursday, January 25, 2024 1 min read
Key Takeaway: Renovaro Biosciences Inc. has announced the results of its Special Meeting of Shareholders, held on January 25, 2024. During the meeting, all proposals put forward to shareholders were approved based on the necessary voting thresholds. This outcome reflects robust support from shareholders for the company's direction and initiatives in cell, gene, and immunotherapy developments. Further details will be made available in the Company's Form 8-K, to be filed with the SEC.

Market Sentiment Analysis

POSITIVE FACTORS

  • All matters presented were approved by shareholders.
  • Demonstrates strong shareholder confidence and support for the Company.
  • Highlights the continued progress of advanced therapeutic platforms.

Full Press Release Details

Renovaro Biosciences Announces Results of Special Meeting of
Los Angeles, January 25, 2024 (GLOBE NEWSWIRE) -
Renovaro Biosciences Inc. (NASDAQ: RENB) (the "Company"), a biotechnology corporation focusing on cell, gene, and immunotherapy,
announced today the results of the Company's Special Meeting of Shareholders held at 12:00 pm ET on January 25, 2024.
All of the matters put forward before the Company's shareholders
for consideration and approval, as set out in the Company's definitive proxy statement dated January 3, 2024, were approved
by the requisite number of votes cast at the meeting.
For complete results on all matters voted on at the meeting, please
consult the Company's Form 8-K which will be filed on EDGAR at www.sec.gov/edgar.
Renovaro has developed advanced cell, gene, and immunotherapy platforms
designed to renew the body's natural tumor-fighting capabilities against cancer and infectious diseases. For more information
on Renovaro, go to their website at www.renovarobio.com.
Contact: ir@renovarobio.com
Source: Renovaro Bioscience Inc.

Frequently Asked Questions

What date was the Special Meeting of Renovaro Biosciences held?

The Special Meeting was held on January 25, 2024.

What was the outcome of the Special Meeting of Shareholders?

All proposed matters were approved by the requisite votes.

Where can I find the complete results of the meeting?

Complete results are available in the Company's Form 8-K on EDGAR.

What does Renovaro Biosciences specialize in?

Renovaro focuses on cell, gene, and immunotherapy for cancer and diseases.

How can I contact Renovaro Biosciences for inquiries?

You can contact them via email at ir@renovarobio.com.

Tags: LNAI Viatris Investor Conferences Healthcare Renovaro Biosciences cell therapy gene therapy immunotherapy
Last updated: Jan 25, 2024